The global Guillain-Barre Syndrome (GBS) Market, valued at US$ 591.3 million in 2022, is projected to grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2031, reaching US$ 890.2 million by 2031. GBS is a rare autoimmune neurological disorder where the immune system attacks peripheral nerves, causing muscle weakness and, in severe cas

The global Mesenchymal Stem Cells (MSCs) Market, valued at US$ 3.2 billion in 2022, is projected to grow at a robust compound annual growth rate (CAGR) of 12.7% from 2023 to 2031, surpassing US$ 10.1 billion by 2031. MSCs, multipotent stem cells derived from bone marrow, adipose tissue, and umbilical cord, are used in regenerative medicine for cond

The global Anticoagulant Reversal Drugs Market, valued at US$ 829.5 million in 2021, is projected to grow at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2031, reaching more than US$ 2.3 billion by 2031. Anticoagulant reversal drugs, such as idarucizumab and andexanet alfa, are used to reverse the effects of anticoagulants in cases of

The global Generic Injectables Market is projected to surpass US$ 307.7 billion by 2031, expanding at a robust compound annual growth rate (CAGR) of 12.3% from 2021 to 2031. Generic injectables, bioequivalent alternatives to branded injectable drugs, are used in oncology, infectious diseases, and cardiovascular conditions, offering cost-effective t

The global Porcine Vaccines Market, valued at US$ 1,784.0 million in 2016, is projected to grow at a compound annual growth rate (CAGR) of over 7.0% from 2017 to 2025, reaching US$ 3,208.8 million by 2025. Porcine vaccines protect swine from diseases like porcine epidemic diarrhea (PED), porcine reproductive and respiratory syndrome (PRRS), and swi